- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03537469
Neuromodulation With Low Frequency-Pulsed Electromagnetic Fields
May 24, 2018 updated by: MAURO MAGONI, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Modulation of Long-Term Potentiation-Like Cortical Plasticity in the Healthy Brain With Low Frequency-Pulsed Electromagnetic Fields
Non-depolarizing magnetic fields, like Low Frequency-Pulsed Electromagnetic Fields (LF-PEMFs) have shown the ability to modulate living structures, principally by influencing synaptic activity and ion channels on cellular membranes.
Recently, the CTU Mega 20 device was presented as a molecular accelerator, using energy up to 200 Joules and providing high-power (2 Tesla) pulsating fields with a water-repulsive (diamagnetic) action and tissue biostimulation.
The investigators tested the hypothesis that LF-PEMFs could modulate long-term corticospinal excitability in healthy brains by applying CTU Mega 20®.
Ten healthy subjects without known neurological and/or psychiatric diseases entered the study.
A randomized double-blind sham-controlled crossover design was employed, recording TMS parameters (amplitude variation of the motor evoked potential as index of cortical excitability perturbations of the motor system) before (pre) and after (post +0, +15, +30 min) a single CTU Mega 20 session on the corresponding primary right-hand motor area, using a real (magnetic field = 2 Tesla; intensity = 90 J; impulse frequency = 7Hz; duration = 15 minutes) or sham device.
A two-way repeated measures ANOVA with TIME (pre, post +0, +15, +30 min) and TREATMENT (real vs sham stimulation) as within-subjects factor was applied.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Early Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy subjects between 18 and 35 years
Exclusion Criteria:
- Known neurological or psychiatric diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: CTU Mega 20 real device
A single-session of real CTU Mega 20 on the corresponding primary right-hand motor area, using the real (magnetic field = 2 Tesla; intensity = 90 J; frequency of impulses = 7Hz; duration = 15 minutes) CTU Mega 20 device.
This real stimulation provided a Low Frequency-Pulsed Electromagnetic Fields (LF-PEMFs).
|
The CTU Mega 20 diamagnetic acceleration system discharges high-field magnetic impulses (with a duration of 5 ms and a period of 1000 ms), generating a magnetic field up to 2 Tesla, with a frequency of 7500 Hz in a volume of approximately 27 cm3.
|
|
SHAM_COMPARATOR: CTU Mega 20 sham device
A single-session of sham CTU Mega 20 on the corresponding primary right-hand motor area (magnetic field = 0 Tesla; intensity = 0 J; frequency of impulses = 7Hz; duration = 15 minutes).
The sham stimulation did not provide a Low Frequency-Pulsed Electromagnetic Fields (LF-PEMFs).
|
A CTU Mega 20 sham device (with an identical appearance to that of the real device) to avoid treatment identification by the patient or experimenter was used.
Of course, the application of this sham device did not provide any magnetic field.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cortical Excitability change across time
Time Frame: Baseline and after 15, and 30 minutes
|
Motor evoked potential (MEP) amplitude registered by TMS after sham or real stimulation at different time points, evaluating the differences among timepoints.
|
Baseline and after 15, and 30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mauro Magoni, MD, U.O. Neurologia Vascolare, Azienda Ospedaliera Spedali Civili, Brescia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 10, 2016
Primary Completion (ACTUAL)
July 1, 2016
Study Completion (ACTUAL)
July 10, 2016
Study Registration Dates
First Submitted
April 29, 2018
First Submitted That Met QC Criteria
May 15, 2018
First Posted (ACTUAL)
May 25, 2018
Study Record Updates
Last Update Posted (ACTUAL)
May 29, 2018
Last Update Submitted That Met QC Criteria
May 24, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- NP-2322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transcranial Magnetic Stimulation
-
University Hospital, GrenobleUnknownHealthy | Transcranial Magnetic Stimulation | Transcranial Direct Current StimulationFrance
-
University of ZurichUniversity Hospital Inselspital, BerneRecruitingTranscranial Magnetic Stimulation | Electric Stimulation TherapySwitzerland
-
Florida State UniversityNational Institute of Mental Health (NIMH)Completed
-
Florida State UniversityNational Institute of Mental Health (NIMH)Completed
-
Institut National de la Santé Et de la Recherche...CompletedTranscranial Magnetic StimulationFrance
-
Florida State UniversityNational Institute of Mental Health (NIMH)Completed
-
University of RegensburgCompletedTranscranial Magnetic Stimulation
-
Florida State UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Yi YangRecruitingTranscranial Magnetic StimulationChina
-
NYU Langone HealthWithdrawn
Clinical Trials on CTU Mega 20 real device
-
Real Imaging Ltd.Terminated
-
Real Imaging Ltd.Unknown
-
Real Imaging Ltd.TerminatedBreast CancerUnited States
-
Real Imaging Ltd.Unknown
-
Real Imaging Ltd.Unknown
-
Aalto UniversityHelsinki University Central Hospital; Business FinlandCompleted
-
Oxford University Hospitals NHS TrustUniversity of OxfordCompletedOsteoarthritis, Knee
-
Xiangya Hospital of Central South UniversityRecruitingA Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment SystemSkin Diseases | Artificial Intelligence | Augmented Reality | Medical ImagingChina
-
Fundación para la Formación e Investigación de...Instituto de Salud Carlos IIINot yet recruitingHypertension | Blood Pressure Measurement | Blood Pressure